Cargando…

Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line

Recombinant monoclonal antibodies (mAbs) against tumor necrosis factor alpha are widely used in the biopharmaceutical therapy of autoimmune diseases. Currently, a large number of drugs based on these antibodies are available. Accordingly, the development of these products for the Russian market is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voronina, E. V., Seregin, Y. A., Litvinova, N. A., Shvets, V. I., Shukurov, R. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025404/ https://www.ncbi.nlm.nih.gov/pubmed/27652157 http://dx.doi.org/10.1186/s40064-016-3213-2

Ejemplares similares

Characterization of recombinant IgA producing CHO cell lines by qPCR
por: Reinhart, David, et al.
Publicado: (2013)

Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β
por: Chen, Weiye, et al.
Publicado: (2011)

Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
por: Ryu, Jina, et al.
Publicado: (2022)

Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines
por: Li, Jing, et al.
Publicado: (2019)

Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibody
por: Carrillo-Cocom, L. M., et al.
Publicado: (2014)

Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
por: Ghorbaniaghdam, Atefeh, et al.
Publicado: (2014)

Correction: Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
Publicado: (2014)

Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
por: Diekmann, Sonja, et al.
Publicado: (2011)

Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies
por: Noh, Soo Min, et al.
Publicado: (2018)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production
por: O’Rourke, Sara M., et al.
Publicado: (2018)

Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
por: Manieri, Tania Maria, et al.
Publicado: (2022)

MALDI-TOF mass spectrometry biotyping: At line monitoring of recombinant CHO cell cultures
por: Schwamb, Sebastian, et al.
Publicado: (2015)

Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
por: Chromikova, Veronika, et al.
Publicado: (2017)

Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011)

Development of a Stable MGAT1(−) CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies
por: Doran, Rachel C., et al.
Publicado: (2018)

Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile
por: Legmann, Rachel, et al.
Publicado: (2011)

The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines
por: Edros, Raihana, et al.
Publicado: (2014)

Multi-omics approach for comparative studies of monoclonal antibody producing CHO cells
por: Orellana, Camila A, et al.
Publicado: (2015)

CHO cell lines generated by PiggyBac transposition
por: Matasci, Mattia, et al.
Publicado: (2011)

Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification
por: Orlova, N. A., et al.
Publicado: (2012)

Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
por: Sowa, Steven W., et al.
Publicado: (2020)

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
por: Chung, Nancy PY, et al.
Publicado: (2014)

Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
por: Toporova, V. A., et al.
Publicado: (2023)

Evidence for co-translational misincorporation of non-canonical amino acid hydroxyproline in recombinant antibodies produced in Chinese Hamster Ovary (CHO) cell lines
por: Boddapati, Shanta, et al.
Publicado: (2020)

Label‐free live cell imaging by Confocal Raman Microscopy identifies CHO host and producer cell lines
por: Prats Mateu, Batirtze, et al.
Publicado: (2016)

Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011)

Stable overexpression of miR-17 enhances recombinant protein production of CHO cells()
por: Jadhav, Vaibhav, et al.
Publicado: (2014)

Rich production media as a platform for CHO cell line development
por: Kim, Yong Jae, et al.
Publicado: (2020)

Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimization
por: Bheemareddy, Bala Reddy, et al.
Publicado: (2022)

Identification of microRNAs specific for high producer CHO cell lines using steady-state cultivation
por: Maccani, Andreas, et al.
Publicado: (2014)

The Use of Transcription Terminators to Generate Transgenic Lines of Chinese Hamster Ovary Cells (CHO) with Stable and High Level of Reporter Gene Expression
por: Gasanov, N. B., et al.
Publicado: (2015)

Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells
por: Škulj, Mihaela, et al.
Publicado: (2014)

Proteomic differences in recombinant CHO cells producing two similar antibody fragments
por: Sommeregger, Wolfgang, et al.
Publicado: (2016)

The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
por: Tian, Weihua, et al.
Publicado: (2019)

Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines
por: Tian, Jun, et al.
Publicado: (2020)

A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies
por: Roy, Gargi, et al.
Publicado: (2018)

Accelerating stable recombinant cell line development by targeted integration
por: Rehberger, Bernd, et al.
Publicado: (2013)

A Highly Productive CHO Cell Line Secreting Human Blood Clotting Factor IX
por: Kovnir, S. V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_09rigcg0speb4h61v3kcv6vi7i